Tirzepatide Dosing Chart: Titration Schedule and Weight-Based Protocol

Tirzepatide Dosing Chart: Titration Schedule and Weight-Based Protocol

A tirzepatide dosing chart outlines the recommended escalation schedule for this dual GIP/GLP-1 receptor agonist, typically starting at 2.5mg weekly and increasing incrementally to a maintenance dose between 5mg and 15mg based on individual response and tolerance. The standard titration protocol spaces dose increases four weeks apart, allowing your body to adapt while minimizing gastrointestinal side effects that can derail treatment adherence. Understanding the dosing schedule isn't just about following instructions—it's about optimizing metabolic outcomes while managing the real-world challenges of nausea, vomiting, and appetite suppression that hit hardest during those first few weeks.

Most clinicians won't tell you this upfront, but there's a significant gap between FDA-approved Mounjaro dosing and what's happening in compounding pharmacies and clinical weight loss practices. We'll break down both.

What Is the Tirzepatide Dosing Schedule?

The tirzepatide dosing schedule is a structured escalation plan designed to minimize side effects while maximizing metabolic benefits. You start low, increase slowly, and stay at each dose for at least four weeks before moving up.

Here's why that matters: tirzepatide slows gastric emptying dramatically. Your stomach literally takes longer to process food. If you jump to a high dose too fast, you're asking for persistent nausea, vomiting, and potentially dangerous dehydration. The titration schedule gives your GI system time to recalibrate.

The FDA-approved schedule for Mounjaro (brand-name tirzepatide) follows a specific pathway. Starting dose: 2.5mg subcutaneously once weekly. After four weeks, you move to 5mg. Then 7.5mg, 10mg, 12.5mg, and finally 15mg—each separated by four-week intervals. That's a six-month ramp if you go all the way to the maximum dose.

But here's where clinical practice diverges. Some patients plateau at 5mg or 7.5mg and don't need higher doses. Others respond better to extended time at intermediate doses—maybe eight weeks at 10mg instead of the standard four. Weight loss isn't linear, and neither should dosing be if the protocol isn't working for your specific metabolism.

Compounded tirzepatide often uses the same increments, though some compounding pharmacies offer additional intermediate doses like 3mg or 6mg for patients who experience significant side effects during standard jumps. There's no clinical trial data supporting these micro-titrations, but anecdotally they help some people stick with treatment who'd otherwise quit.

The Standard Titration: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg

Let's map out what each dose level typically delivers in terms of weight loss and side effect profile. This isn't gospel—individual variation is massive—but it reflects patterns from the SURMOUNT trials and real-world clinical observation.

The 2.5mg starting dose is intentionally sub-therapeutic. You probably won't lose much weight. That's fine—it's a priming dose to introduce your GI tract to delayed gastric emptying without overwhelming it. Some patients get frustrated here because they're paying for medication that "doesn't work yet." Stick with it.

At 5mg, things get real. This is where most people start noticing significant appetite suppression and consistent weekly weight loss. It's also where nausea becomes a daily consideration. Eating smaller meals, avoiding high-fat foods, and staying hydrated become non-negotiable habits.

The jump from 7.5mg to 10mg is often the hardest transition. That's a 33% dose increase, and your stomach knows it. If you're going to experience vomiting or severe nausea that requires anti-emetics, it'll likely happen here. Some practitioners recommend staying at 7.5mg for eight weeks instead of four before attempting the move to 10mg.

Not everyone needs 15mg. In fact, the SURMOUNT-1 trial showed that while higher doses generally produced more weight loss, the difference between 10mg and 15mg wasn't always clinically significant for every participant. If you're hitting your goals at 10mg with manageable side effects, there's no compelling reason to push higher just because the chart says you can.

Why Titration Matters: GI Tolerance and Receptor Desensitization

Titration isn't just a cautious medical formality—it's physiologically necessary for two distinct reasons: gastrointestinal adaptation and receptor regulation.

First, the GI piece. Tirzepatide activates GLP-1 receptors throughout your digestive tract, which slows the movement of food from your stomach to your intestines. This delay is part of how the drug works—it keeps you feeling full longer and dampens hunger signals. But if you slam your system with a high dose immediately, your stomach essentially stops moving. Food sits there. You feel nauseated. You might vomit. In extreme cases, you risk gastroparesis—a condition where stomach paralysis persists even after stopping the medication.

Slow titration lets the smooth muscle in your GI tract gradually adjust to the new normal. Over four weeks at each dose, your body recalibrates what "normal" gastric motility looks like. Jump too fast, and you're fighting against biology.

Second, receptor dynamics. While tirzepatide doesn't cause classic tachyphylaxis (where receptors downregulate in response to chronic stimulation), there is an adaptation period. GIP and GLP-1 receptors modulate their sensitivity based on sustained agonist exposure. Gradual dose escalation may optimize receptor activity without triggering compensatory mechanisms that could blunt efficacy over time. The science here isn't fully settled, but the clinical pattern suggests that patients who titrate slowly often maintain better long-term response than those who rush to maximum doses.

There's also a psychological component. Appetite suppression at high doses can be so profound that eating becomes unpleasant. If you're not mentally prepared for that shift, it can lead to disordered eating patterns or treatment discontinuation. Titration gives you time to adapt not just physically, but behaviorally—to relearn hunger cues, portion sizes, and food relationships in a controlled way.

Skipping titration steps or accelerating the schedule is risky. Some patients try to "hack" the system by increasing doses every two weeks instead of four, hoping to reach maximum weight loss faster. This almost always backfires. You end up so sick you can't function, and you're more likely to quit entirely. Slow and steady wins the metabolic race here.

Clinical Trial Doses vs Real-World Clinical Practice

The SURMOUNT trials established tirzepatide's efficacy using a strict protocol: 2.5mg initiation, then 2.5mg increases every four weeks up to the randomized maintenance dose (5mg, 10mg, or 15mg). Participants didn't deviate. They followed the schedule, reported side effects, and got monitored closely.

Real-world clinical practice? It's messier. And honestly, often better tailored to individual needs.

In weight management clinics, you'll see practitioners holding patients at 5mg or 7.5mg for extended periods—sometimes months—if weight loss is progressing well and side effects are minimal. Why increase the dose and risk derailing adherence if the current dose is working? The goal is sustainable weight loss, not hitting a maximum dose for its own sake.

You'll also see more flexible titration with compounded tirzepatide. Since compounding pharmacies can prepare custom concentrations, some clinicians use intermediate doses like 3mg, 6mg, or 9mg to smooth out the escalation curve. There's no clinical trial data backing these doses specifically, but the pharmacology is straightforward—tirzepatide's dose-response curve is relatively linear, so a 6mg dose should sit predictably between 5mg and 7.5mg in terms of efficacy and side effects.

Another departure: dose reductions. The trials didn't allow stepping back down if side effects emerged—you either stayed at your assigned dose or dropped out. In practice, if a patient moves from 10mg to 12.5mg and experiences intolerable nausea, a good clinician will drop them back to 10mg rather than lose them to discontinuation. That's not protocol deviation—that's rational prescribing.

We also see "pulsing" strategies in some practices, where patients alternate between higher and lower doses week-to-week to maintain efficacy while reducing cumulative side effect burden. For example, alternating 10mg and 7.5mg weekly instead of straight 10mg. There's limited evidence supporting this approach, but anecdotal reports suggest it works for some people who can't tolerate consistent high-dose exposure.

Telehealth platforms tend to stick closer to the FDA schedule because they're operating at scale with less individualized monitoring. That's not necessarily wrong, but it does mean you might not get the flexibility that an in-person weight management specialist could offer.

Weight-Based Dosing: Does Body Weight Affect Optimal Dose?

Here's a question that comes up constantly: should tirzepatide dosing be adjusted based on body weight? If you weigh 180 pounds versus 280 pounds, do you need different doses to achieve the same metabolic effect?

The short answer: not according to current FDA prescribing guidelines. Tirzepatide dosing is the same regardless of baseline body weight. A 150-pound person and a 300-pound person both start at 2.5mg and follow the same titration schedule.

The longer answer: weight might matter, but we don't have enough data to create validated weight-based protocols yet.

Pharmacokinetic studies show that tirzepatide exposure (measured as area under the curve) does vary with body weight—heavier individuals tend to have slightly lower drug concentrations at the same dose. But those differences are relatively modest, and they didn't translate into significant differences in weight loss outcomes in the SURMOUNT trials. The trials enrolled people across a wide BMI range (27-50+ kg/m²), and the standard fixed-dose schedule worked across that spectrum.

That said, clinical observation suggests some patterns. Very large individuals (BMI >45) sometimes need to push to 12.5mg or 15mg to see the same percentage body weight loss that average-BMI patients achieve at 7.5mg or 10mg. Conversely, smaller individuals sometimes find their sweet spot at 5mg or 7.5mg and don't benefit from going higher.

There's also the question of lean body mass versus fat mass. Two people with the same total body weight but different body compositions might respond differently to the same dose. Someone with more muscle mass may metabolize the drug differently than someone with proportionally more adipose tissue. We don't have precision dosing tools for this yet, but it's an area of active investigation.

For now, the best approach is individualized titration based on response and tolerability rather than rigid adherence to weight-based formulas. If you're losing 1-2% of body weight per week at 7.5mg and feeling fine, there's no reason to escalate just because a chart says to. Conversely, if you've plateaued at 10mg after 12 weeks with no further progress, trying 12.5mg might make sense—regardless of your starting weight.

One practical consideration with weight management protocols: as you lose significant weight, your metabolic needs change. Some patients find they need to adjust their dose downward after losing 15-20% of body weight because the same dose that was well-tolerated at 250 pounds becomes too strong at 200 pounds. This is another area where real-world practice diverges from trial protocols, which generally kept patients at fixed doses throughout the study period.

Compounded Tirzepatide Dosing Considerations

Compounded tirzepatide has flooded the weight loss market, offering the same active pharmaceutical ingredient at a fraction of Mounjaro's cost. But dosing gets trickier when you're working with compounded formulations instead of FDA-approved pre-filled pens.

First, the obvious: compounded tirzepatide is prepared by licensed pharmacies using bulk API (active pharmaceutical ingredient), not manufactured by Eli Lilly. The chemical is identical, but the formulation might differ. Some compounding pharmacies use lyophilized powder that you reconstitute with bacteriostatic water; others provide pre-mixed solutions. Concentration varies—you might get a vial with 5mg/ml, 10mg/ml, or custom concentrations based on the prescriber's request.

This means you need to know how to calculate your dose accurately. If your prescribed dose is 7.5mg and your vial is 10mg/ml, you're drawing 0.75ml. Get that math wrong, and you're either underdosing (wasting money and slowing progress) or overdosing (hello, projectile vomiting). Most compounding pharmacies provide dosing charts with the medication, but double-check their math. Errors happen.

Volume per injection also matters for comfort. Drawing a larger volume (say, 1ml versus 0.3ml) means a bigger subcutaneous injection, which can be more painful and increase the risk of injection site reactions. Some patients request more concentrated formulations specifically to minimize injection volume once they're at higher doses.

Stability is another issue. FDA-approved Mounjaro is shelf-stable for months when refrigerated. Compounded tirzepatide typically has a shorter beyond-use date—often 30-60 days once reconstituted, sometimes longer for pre-mixed formulations. If you're following a standard titration schedule and staying at each dose for four weeks, you'll go through vials relatively quickly. But if you're on a maintenance dose and using smaller amounts, you might waste medication as vials expire.

Quality control varies between compounding pharmacies. Reputable ones use third-party testing to verify potency and sterility; others don't. If you're getting wildly inconsistent effects from the "same" dose month-to-month, suspect formulation variability. This isn't common with high-quality compounders, but it happens enough to mention.

Dosing flexibility is one advantage of compounded tirzepatide. As mentioned earlier, you can request custom intermediate doses (3mg, 6mg, 9mg) that aren't available with Mounjaro's fixed-dose pens. You can also fine-tune doses in 0.5mg increments if you're working with a provider who wants that level of precision. The downside? More opportunity for dosing errors if you're not confident with calculations and syringe measurements.

Insurance doesn't cover compounded tirzepatide, so you're paying out of pocket. But at $200-400/month versus $1,000+ for Mounjaro without coverage, the math works for most people. Just factor in the cost of supplies—syringes, alcohol swabs, sharps containers—which add up over time.

Dose Adjustments: When to Slow Down or Hold

Not every titration schedule runs smoothly. Sometimes you need to pump the brakes, hold at a current dose longer, or even step back down. Here's when to consider adjustments.

Persistent nausea lasting more than two weeks at a new dose is a red flag. Some nausea is expected during the first week after increasing—that's your GI system recalibrating. But if you're still nauseated daily at week three, you've probably outpaced your tolerance. Options: stay at the current dose for another 4-8 weeks instead of escalating, or drop back to the previous dose and try a slower re-escalation later.

Vomiting more than once or twice per week is not acceptable. That's a sign of severe GI distress and puts you at risk for dehydration and electrolyte imbalances. If you're vomiting frequently, reduce your dose immediately and consult your provider. You might need anti-emetics like ondansetron or metoclopramide to bridge the gap, or you might need to settle at a lower maintenance dose permanently.

Rapid weight loss (more than 2-3 pounds per week sustained over multiple weeks) can be too much, too fast. Yeah, I know—that sounds like a good problem. But losing weight at that rate increases the risk of gallstones, muscle loss, nutritional deficiencies, and hair loss. If you're shedding weight faster than expected, consider holding your current dose rather than escalating. You'll still reach your goal, just more sustainably.

Inability to meet protein or hydration targets is another reason to pause. If your appetite is so suppressed that you can't consume adequate protein (aim for at least 60-80g daily) or fluids (minimum 64oz water), you risk muscle wasting and dehydration. This is especially common at 10mg and above. Sometimes the solution is better meal planning; other times it means your dose is too high for your current lifestyle and eating capacity.

Medical contraindications can emerge during treatment. If you develop pancreatitis symptoms (severe upper abdominal pain radiating to the back), you need to stop tirzepatide immediately. Same with gallbladder issues—if you develop right upper quadrant pain, nausea after eating fatty foods, or jaundice, that's a potential gallstone situation, and continuing tirzepatide could worsen it. Your provider might have you hold dosing until the issue is resolved, then restart at a lower dose or switch to a different medication entirely.

Plateaus are normal and don't always require dose changes. If weight loss stalls for 2-4 weeks but you're tolerating your current dose well, that might just be your body's metabolic adaptation kicking in. Testing metabolic markers can help determine whether it's time to increase the dose or if other factors (diet, activity, sleep, stress) need addressing first.

Listen to your body. If a dose feels wrong—not just uncomfortable during the adjustment period, but persistently wrong—advocate for a change. You know your body better than a standardized chart does.

Missing a Dose: What the Prescribing Information Says

Life happens. You forget your injection, you're traveling without refrigeration, your shipment gets delayed. Here's how to handle missed doses without derailing your progress.

If you miss a dose and remember within four days (96 hours), take it as soon as you remember. Then resume your regular weekly schedule from that point. For example, if you normally inject on Mondays but forget until Thursday, take your injection Thursday and shift to Thursdays going forward. Or take it Thursday and skip one day to get back to Monday the following week. Either approach works—just maintain the weekly frequency.

If more than four days have passed since your missed dose, skip it entirely and take your next dose on the regularly scheduled day. Don't double up. Taking two doses close together significantly increases the risk of severe nausea and vomiting without providing additional benefit.

Here's where it gets tricky: if you miss multiple weeks—say, you run out of medication and can't get a refill for two or three weeks—you might need to restart titration from a lower dose. Tirzepatide has a half-life of about five days, so after two weeks without dosing, you're essentially back to baseline. Jumping back in at 10mg or 12.5mg after that gap is asking for trouble. Most providers recommend restarting 1-2 dose levels below where you were (so if you were at 10mg, restart at 5mg or 7.5mg) and re-titrate over a few weeks.

Intentional dose skipping—like trying to take tirzepatide every 10-14 days instead of weekly—isn't recommended based on current prescribing information. The drug is dosed weekly because that's what the pharmacokinetics support for stable blood levels and consistent metabolic effects. Stretching the interval might save money in the short term but typically results in inconsistent appetite suppression, weight loss plateaus, and more pronounced side effects when you do take the dose (because you're yo-yoing between high and low drug concentrations).

That said, some patients in maintenance phase experiment with extended dosing intervals—like taking their dose every 10 days instead of 7—if they've reached their goal weight and are just trying to maintain. There's no clinical evidence supporting this, but anecdotally it works for some people. If you try this, monitor your weight closely and be prepared to return to weekly dosing if you start regaining.

Medication shortages have been a recurring issue with both Mounjaro and compounded tirzepatide. If you know you're going to miss doses due to supply problems, communicate with your provider early. They might be able to source from a different pharmacy, adjust your dose to stretch your current supply, or bridge you with a different GLP-1 agonist temporarily.

Maintenance Dosing: What Happens After Target Weight

You've hit your goal weight. Now what? Do you stay on tirzepatide forever? Can you reduce your dose? Will you regain weight if you stop?

The SURMOUNT trials included a withdrawal phase where participants stopped tirzepatide after 36 weeks. Result: most people regained a significant portion of the weight they'd lost, though not all of it. This isn't surprising—tirzepatide treats the metabolic dysfunction that drives obesity, but it doesn't cure it. Stop the medication, and the underlying biology reasserts itself.

For most people, maintenance dosing means continuing tirzepatide indefinitely at the lowest effective dose that maintains your target weight. That might be the dose you were on when you reached your goal (say, 10mg), or it might be a reduced dose (dropping to 7.5mg or even 5mg) if you find that's sufficient to prevent regain.

Some patients do well with reduced-frequency dosing during maintenance. Instead of 7.5mg weekly, maybe 7.5mg every 10 days, or alternating 7.5mg and 5mg weekly. This is off-label territory without robust evidence, but it's a rational approach if you're stable and want to minimize cost and side effects. Monitor your weight closely—if you start trending upward consistently, you need to return to full weekly dosing.

Transitioning to lifestyle maintenance without medication is possible but difficult. If you've made substantial changes to diet, exercise, sleep, and stress management during your weight loss phase, you might be able to maintain without tirzepatide. But realistically, most people who stop the medication regain weight over 6-12 months. That's not a moral failing—it's physiology. Obesity involves complex hormonal and metabolic dysregulation that doesn't resolve just because you lost weight.

Intermittent treatment is another approach: use tirzepatide for 6-12 months to lose weight, stop for a period while maintaining with lifestyle interventions, then restart if you begin regaining. Some people find this pattern sustainable long-term, especially if cost is a limiting factor. It's not ideal from a metabolic health standpoint (weight cycling has its own risks), but it's better than regaining all the weight and staying there.

Combining tirzepatide with other interventions during maintenance might allow dose reduction. For example, if you're also working on metabolic health through longevity-focused protocols—improving insulin sensitivity with exercise, optimizing sleep, managing stress, potentially adding metformin or berberine—you might maintain weight loss at a lower tirzepatide dose than you'd need with medication alone.

Cardiovascular and metabolic benefits might justify continued dosing even if weight loss isn't the primary goal anymore. Tirzepatide improves blood pressure, lipid profiles, inflammatory markers, and potentially heart disease risk independent of weight loss. If you're using it as part of a broader metabolic health strategy, staying on a maintenance dose makes sense even after reaching your target weight.

Insurance coverage is a wild card for maintenance dosing. Some plans cover tirzepatide for diabetes (as Mounjaro) but not for weight management (as Zepbound), so if you're using it purely for weight maintenance without diabetes, you might lose coverage and need to switch to compounded tirzepatide or pay out of pocket. Plan for that possibility financially.

Frequently Asked Questions

Can I start tirzepatide at a higher dose than 2.5mg to lose weight faster?

No, and you shouldn't want to. Starting at 5mg or higher dramatically increases your risk of severe nausea, vomiting, and treatment discontinuation. The 2.5mg starting dose exists to prime your GI system for higher doses. Skipping it almost always backfires. Slow titration leads to better adherence and ultimately more sustainable weight loss than trying to rush the process.

How long should I stay at each dose before increasing?

Standard protocol is four weeks per dose level. But if you're still experiencing significant side effects at week four, there's no harm in staying at your current dose for another 4-8 weeks before escalating. Some patients do better with extended titration, especially at the higher dose levels (10mg, 12.5mg, 15mg). Listen to your body more than the calendar.

What if I'm not losing weight at the maximum dose?

If you've reached 15mg and plateaued without hitting your weight loss goals, first evaluate other factors: are you accurately tracking food intake? Getting adequate sleep? Managing stress? Exercising regularly? Sometimes the issue isn't the medication. If those factors are optimized and you're still not responding, you might be a non-responder to tirzepatide (about 10-15% of people don't get significant benefit). In that case, switching to a different medication class or adding combination therapy might be necessary. Discuss options with your provider.

Can I split my weekly dose into smaller, more frequent injections?

Technically yes, but it's not recommended. Tirzepatide's pharmacokinetics are designed for once-weekly dosing. Splitting into twice-weekly or daily injections changes the blood concentration curve and might alter efficacy and side effects in unpredictable ways. More injections also mean more injection site reactions and more hassle. Stick with weekly dosing unless you have a very specific medical reason to deviate, and even then, discuss it with your provider first.

Do I need to inject at the same time every week?

Same day is important; same time is less critical. Tirzepatide has a long half-life (about five days), so small variations in injection timing—a few hours earlier or later than usual—won't significantly impact blood levels or efficacy. But you should try to maintain the same day of the week for consistency. If you inject Monday morning one week and Monday evening the next, that's fine. Injecting Monday one week and Wednesday the next is less ideal.

What should I do if I experience severe nausea that won't go away?

First, try conservative measures: eat smaller, more frequent meals; avoid high-fat foods; stay hydrated; use ginger or peppermint. If nausea persists beyond two weeks or significantly impacts your quality of life, contact your provider. You might benefit from prescription anti-nausea medications like ondansetron or promethazine. If nausea remains intolerable even with supportive treatment, reducing your dose is completely reasonable. There's no prize for suffering through side effects.

Is there a maximum safe dose of tirzepatide above 15mg?

The FDA-approved maximum is 15mg weekly. Higher doses haven't been studied in large trials for safety or efficacy. Some clinicians might prescribe higher doses off-label in exceptional cases, but that's uncommon and carries unknown risks. More isn't always better—side effects increase with dose, and the weight loss curve tends to plateau at higher doses for most people. If 15mg isn't getting you to goal, adding a different intervention is usually smarter than pushing tirzepatide higher.

Can I drink alcohol while on tirzepatide?

Yes, but proceed carefully. Tirzepatide slows gastric emptying, which can alter alcohol absorption and potentially increase intoxication from the same amount you're used to drinking. You might also find alcohol less appealing—many people on GLP-1/GIP agonists report reduced interest in drinking. If you do drink, start with smaller amounts than usual and monitor your response. Alcohol can also worsen nausea and dehydration, so stay hydrated and eat before drinking.

Should I take tirzepatide with or without food?

It doesn't matter—tirzepatide can be injected without regard to meals. It's a subcutaneous injection, not an oral medication, so food in your stomach doesn't affect absorption. That said, many people prefer to inject at a consistent time relative to their eating schedule (for example, before breakfast or before bed) just to establish a routine. Find what works for you and stick with it.

What happens if I accidentally inject twice the dose?

Contact your healthcare provider immediately. A double dose significantly increases the risk of severe hypoglycemia (if you're also on diabetes medications), nausea, vomiting, and dehydration. Monitor yourself closely for symptoms: shakiness, sweating, confusion (signs of low blood sugar), persistent vomiting, inability to keep fluids down. If symptoms are severe, seek emergency medical care. Don't take your next scheduled dose—your provider will tell you when to resume and at what dose.

Can I switch between brand-name Mounjaro and compounded tirzepatide?

Yes, the active ingredient is the same. If you're switching from Mounjaro to compounded tirzepatide, continue at the same dose you were taking. If switching from compounded to Mounjaro, same principle applies. The main difference is delivery mechanism (auto-injector pen versus manual syringe draw) and potentially formulation excipients, but these shouldn't affect efficacy. Some people report feeling differences when switching, but that's likely placebo or variation in compounding quality rather than a true pharmacological difference.

Do I need to refrigerate tirzepatide between doses?

Yes, both Mounjaro pens and most compounded tirzepatide formulations should be stored in the refrigerator (36-46°F) when not in use. Tirzepatide degrades at room temperature over time. You can keep pens or vials at room temperature for short periods (up to 21 days for Mounjaro), which is helpful for travel, but long-term storage should be refrigerated. Never freeze tirzepatide—freezing destroys the peptide structure and renders it ineffective.

Will I regain all the weight if I stop tirzepatide?

Most people regain some weight after stopping, but not necessarily all of it. In the SURMOUNT withdrawal study, participants regained about 14% body weight over 52 weeks after stopping, which was roughly half of what they'd lost during treatment. Individual results vary widely based on lifestyle changes maintained after discontinuation. If you've fundamentally changed your eating habits, activity level, and metabolic health during treatment, you'll keep more weight off than someone who relied solely on medication without behavior change.

Can I use tirzepatide if I've had bariatric surgery?

Possibly, but it requires careful consideration. Some patients who've had gastric sleeve or bypass surgery use tirzepatide later for weight regain. However, the combination of surgically-altered anatomy and tirzepatide's effects on gastric emptying can increase risks of severe nausea, vomiting, and nutritional deficiencies. If you're considering tirzepatide post-bariatric surgery, work with a provider experienced in both areas. You'll likely need more conservative dosing, closer nutritional monitoring, and possibly supplemental support.

How do I know when I've found my optimal maintenance dose?

Your optimal dose is the lowest dose that maintains your target weight with tolerable side effects. If you're at 10mg, stable at goal weight, and feeling good, try reducing to 7.5mg and monitor for 8-12 weeks. If weight stays stable, you might try dropping to 5mg. If you start trending upward, return to the previous dose. This is a trial-and-error process. Some people need higher maintenance doses than others based on individual metabolic factors. There's no universal answer—it's about finding your personal sweet spot.